None

Human medicines European Public Assessment Report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan / hydrochlorothiazide, Revision: 16, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop), irbesartan / hydrochlorothiazide, Revision: 15, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 4, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan/Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 5, Authorised

Human medicines European Public Assessment Report (EPAR): Irbesartan / Hydrochlorothiazide Teva, irbesartan / hydrochlorothiazide, Revision: 4, Authorised

Chlorthalidone no better than hydrochlorothiazide for HTN

(HealthDay)—For older adults with hypertension, chlorthalidone is not associated with fewer adverse cardiovascular events or death, but correlates with increased hypokalemia compared with hydrochlor...

US FDA approves Mylan Valsartan and Hydrochlorothiazide tablets

Mylan Pharmaceuticals, a subsidiary of Mylan, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Valsartan and Hydrochloroth...

Par Pharmaceutical Begins Shipment of Generic Atacand HCT®

WOODCLIFF LAKE, N.J., Dec. 5, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive U.S. supply...

Spectrofluorimetric Assessment of Hydrochlorothiazide Using Optical Sensor Nano-Composite Terbium Ion Doped in Sol-Gel Matrix.

A new, simple, sensitive and selective spectrofluorimetric method for the determination of Hydrochlorothiazide was developed in acetonitrile at pH 6.2. The Hydrochlorothiazide can remarkably enhance t...

24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.

To determine the effectiveness and safety of once-daily combination therapy with amlodipine, valsartan and hydrochlorothiazide for reducing ambulatory blood pressure (ABP) in patients with moderate to...

Diuretics in the treatment of hypertension : Efficacy, safety and tolerability.

In the treatment of hypertension, both the thiazide diuretics hydrochlorothiazide and bendroflumethiazide and the "thiazide-like" diuretics chlorthalidone and indapamide are used. Guidelines refer to...

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non...

Which Diuretic Is the Preferred Agent for Treating Essential Hypertension: Hydrochlorothiazide or Chlorthalidone?

Since their introduction over 50 years ago thiazide and thiazide-like diuretics have been a mainstay in the treatment of hypertension. Yet despite outcome evidence with chlorthalidone, the prepondera...